Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
2009 StandoutNobel
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
2011
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Addition of a Low Fixed Number of CD3 + Cells to CD34-Enriched Allografts: Effects on Engraftment, Graft-versus-Host Disease, and Survival after Related and Unrelated Peripheral Stem Cell Transplantation
2003
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation
2004
Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation
1999
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation
2005
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Prognostic relevance of ‘early‐onset’ graft‐versus‐host disease following non‐myeloablative haematopoietic cell transplantation
2005
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients
2002
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Cytokine Inhibitors and Graft‐versus‐Host Disease
1995
Bloodstream Infection after Umbilical Cord Blood Transplantation Using Reduced-Intensity Stem Cell Transplantation for Adult Patients
2005
Diagnosis and management of refractoriness to platelet transfusion
2001
Cytomegalovirus and Lung Transplantation
2004
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
2004
INCREASED EXPRESSION OF TISSUE CYTOKINES IN GRAFT-VERSUS-HOST DISEASE AFTER SMALL BOWEL TRANSPLANTATION IN THE RAT1
1997
Techniques for blood administration in sickle cell patients
2001
Haematopoietic cell transplantation as immunotherapy
2001 Nature
Congenital cytomegalovirus infection: Outcome and diagnosis
2005
Transfusion Medicine — Blood Transfusion
1999 Standout
Graft-versus-host disease and the Th1/Th2 paradigm
1996
Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance
2003 StandoutNobel
Vascular disorders of the liver # †
2008 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Extending Postgrafting Cyclosporine Decreases the Risk of Severe Graft-versus-Host Disease after Nonmyeloablative Hematopoietic Cell Transplantation
2006
Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath ‘in the bag’ as T-cell depletion: the Leiden experience
2006
Induction of Cytomegalovirus-Specific T Cell Responses in Healthy Volunteers and Allogeneic Stem Cell Recipients Using Vaccination With Messenger RNA–Transfected Dendritic Cells
2014
Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
1999 StandoutNobel
Levels of CMV Specific CD4 T Cells Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation
2008
Graft-versus-host disease
2009 Standout
Echinocandin antifungal drugs
2003 Standout
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
1997 StandoutNature
The pathobiology of mucositis
2004 Standout
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
CYTOKINE CASCADES IN ACUTE GRAFT-VERSUS-HOST DISEASE1
1997
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Sickle-cell disease
2010 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
Immunobiology of acute graft-versus-host disease
2003
Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.
1998
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Role of interleukin 10 in specific immunotherapy.
1998 Standout
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Toxicity antagonists in head and neck cancer
1998
Infection in Solid-Organ Transplant Recipients
2007 Standout
Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole
2000
Idiopathic pneumonia after bone marrow transplantation: Cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment
1999
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
2000
Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy Patients
2005
Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation†
2005
Head and Neck Cancer
2001 Standout
Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia
1999
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines
1997
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
2002
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)
1995
Acute Myeloid Leukemia
2015 Standout
Zygomycetes in Human Disease
2000 Standout
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
2004
Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? [see comments]
1994
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
2003
A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation
2008
Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet Transfusions
1997
Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis
1994
Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial
2003
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants
2003
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation
2003
Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Biologic effects of leukocytes present in transfused cellular blood products
1994
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
1994
Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age
2001
IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
1998
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation
2000
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
1997 StandoutScience
Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning
2005
The Danger Model: A Renewed Sense of Self
2002 StandoutScience
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation
2001
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
2005 Standout
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
2004
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial
2000
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells
2010 StandoutNobel
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome
2002
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia
2007
Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspecies
2005 Standout
Successful Modification of a pp65 Antigenemia-Based Early Treatment Strategy for Prevention of Cytomegalovirus Disease in Allogeneic Marrow Transplant Recipients
1999
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
Tolerogenic Dendritic Cells
2003 StandoutNobel
Interleukin-6 Modulates Graft-versus-Host Responses after Experimental Allogeneic Bone Marrow Transplantation
2010
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide
1994
Successful Modification of a pp65 Antigenemia-Based Early Treatment Strategy for Prevention of Cytomegalovirus Disease in Allogeneic Marrow Transplant Recipients
1999
Risks, Costs, and Alternatives to Platelet Transfusions
1999
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy
2003
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen
2003
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders
2002
CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation
2007
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning
2003
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of RA Bowden being referenced
SERUM LEVELS OF INTERLEUKIN 6, INTERLEUKIN 8, AND C-REACTIVE PROTEIN AFTER HUMAN ALLOGENEIC BONE MARROW TRANSPLANTATION
1994
ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATION
1990
Cytomegalovirus pp65 Antigenemia after Autologous Marrow and Peripheral Blood Stem Cell Transplantation
1996
Bordetella bronchiseptica pneumonia and bacteremia following bone marrow transplantation
1992
A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion- associated CMV infection after marrow transplant [see comments]
1995
Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation
1992
Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention
1994
Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant
1991
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation
1993
Brain Abscess Following Marrow Transplantation: Experience at the Fred Hutchinson Cancer Research Center, 1984-1992
1994
Hepatosplenic candidiasis--a contraindication to marrow transplantation?
1994
Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation
1992
Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study
1996
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation
1993
Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant
1991
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate [see comments]
1992